STAT
OCTOBER 28, 2022
Over the past week, Areva Pharmaceuticals began marketing vials of fludarabine at a wholesale price of $2,736, much more than the $272 charged for the same dosage by Fresenius Kabi and the $109 price from Teva Pharmaceuticals. Continue to STAT+ to read the full story…
STAT
JULY 28, 2023
WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 14, 2023
WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies. Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018.
STAT
FEBRUARY 14, 2024
Three group purchasing organizations, or GPOs, buy drugs on behalf of most hospitals in the U.S., The move comes amid growing anxiety over shortages of numerous medicines — from chemotherapies to antibiotics — in recent years.
STAT
JUNE 28, 2023
“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”
STAT
JULY 31, 2023
… House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use , STAT explains. Republicans
pharmaphorum
JULY 16, 2021
The rejection leaves men in England and Wales newly-diagnosed with prostate cancer with three options: hormone therapy on its own, or alongside either Pfizer’s Xtandi (enzalutamide) – recently approved by NICE – or docetaxel chemotherapy.
Expert insights. Personalized for you.
246 
Let's personalize your content